Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01836965
Other study ID # 42565EP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2013
Est. completion date April 9, 2018

Study information

Verified date March 2019
Source Milton S. Hershey Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to validate a social skills training program manual for adolescents (ages 13-17) with Asperger's Syndrome or high functioning autism. Approximately 150 adolescents with autism spectrum disorders will participate in this study, in groups consisting of 6 adolescents and 6 peer volunteers. Participants will participate in both group therapy and peer generalization sessions (in the form of a photography class) once a week over the course of twelve weeks. Participants and their parents will complete paper and pencil, online, or phone measures and video-recordings to assess the participant's social skills prior to the intervention, at completion of the intervention and three months later.


Description:

This study is a pre-test, post-test single group design with post test measures at one week after completion of intervention and follow-up at three months. Approximately 300 adolescents will participate in this study. The study will be conducted in ten cohorts of 12. Each cohort will have 6 participants and 6 adolescent volunteers (peers). Cohorts will be run in a time sequential manner with up to four cohorts running at a time. Participants and their parents will complete pre-test measures including both paper and pencil, online, or phone measures and a video-recording to assess the participant's social interaction skills and fluency. These adolescents will participate in both group therapy and peer generalization sessions once a week over the course of twelve weeks. Upon completion of the intervention, participants and parents will complete paper and pencil, online, or phone measures and video post-test measures. Participants will be encouraged to participate in a follow-up session where the paper and pencil and video measures will be completed again.


Recruitment information / eligibility

Status Completed
Enrollment 155
Est. completion date April 9, 2018
Est. primary completion date April 9, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years to 17 Years
Eligibility Inclusion Criteria:

- Between 13 and 17 years of age

- Must be a Pennsylvania resident

- A primary diagnosis of Asperger's Syndrome or high-functioning autism, as confirmed by the Checklist for Autism Spectrum Disorders (CASD; Mayes, 2012)

- English as primary language spoken

- Ability to fluently speak in full sentences

- A verbal IQ of 85 or above on the Kaufman Brief Intelligence Test, Second Edition(KBIT-2; Kaufman & Kaufman, 1990)

Exclusion Criteria:

- A significant language delay

- Difficulty with aggression directed at peers

- A primary thought disorder

- A secondary disorder of anxiety or depression so severe as to prevent the individual's participation in the treatment

- Low social motivation demonstrated through formalized assessment and/or by responses given to screening interviews assessing treatment goals

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Social Skills Intervention
Twelve week manual based social skills curriculum targeting social fluency and responsiveness.

Locations

Country Name City State
United States Penn State Hershey Psychiatry Clinic Hershey Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Milton S. Hershey Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Social Responsiveness Scale Score after Intervention The Social Responsiveness Scale is a 65 - item survey designed to measure social competence. One Week Post-Intervention
Primary Video recording of Social Interaction Participants will be filmed in a brief interaction with a typically developing peer which will be coded to obtain social interaction skills and fluency scores. One Week Post-Intervention
Secondary Change from Baseline Strengths and Difficulties Questionnaire (SDQ) after Intervention The SDQ is a 25 item survey that asks about positive and negative attributes. One Week Post-Intervention
Secondary Change from Baseline Loneliness Scale after Intervention The Loneliness Scale is a 24-item survey that assesses social and emotional loneliness. One Week Post Intervention
Secondary Change from Baseline Multidimensional Anxiety Scale for Children after Intervention The MASC is a 39-item survey that assesses anxiety symptoms in children. One Week Post-Intervention
Secondary Change from Baseline Strengths and Difficulties Questionnaire (parent form)after Intervention The Strengths and Difficulties Questionnaire is a 25 item survey that asks about positive and negative attributes. One Week Post-Intervention
Secondary Change from Baseline Strengths and Difficulties Questionnaire at 3 month Follow Up 3 Month Follow Up
Secondary Change from Baseline Loneliness Scale at 3-month Follow Up 3 Month Follow Up
Secondary Change from Baseline Multidimensional Anxiety Scale for Children at 3 month Follow Up 3 Month Follow Up
Secondary Change from Baseline Strengths and Difficulties Questionnaire (parent form)at 3 Month Follow Up 3 Month Follow Up
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02625116 - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting NCT06381856 - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting NCT02280746 - Gluten for Autism Spectrum Disorders N/A
Completed NCT01945957 - Brain Imaging of Intranasal Oxytocin Treatment in Autism Phase 1
Completed NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Phase 2
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder Phase 2
Completed NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder N/A
Completed NCT01780090 - Handheld Technology for Speech Development in Students With Autism N/A
Active, not recruiting NCT01417026 - Intranasal Oxytocin and Learning in Autism Phase 2
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Completed NCT01695200 - Omega-3 Fatty Acids in Autism Spectrum Disorders Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Not yet recruiting NCT00695812 - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT02081027 - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Early Phase 1
Completed NCT02797379 - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT01603225 - Transcranial Direct Current Stimulation and Autism